
Distinguish RBQM from RBM, identify Critical to Quality factors, and establish a practical implementation approach aligned with ICH E8(R1) and ICH E6(R3).
Includes live access & recording
This course helps clinical trial teams distinguish RBQM from RBM, identify Critical to Quality factors, and establish a practical implementation approach aligned with ICH E8(R1) and ICH E6(R3).
The webinar examines the principles of RBQM, their relationship with RBM, and the practical implications of both guidelines. Participants will consider how Critical to Quality factors are identified, what a risk-proportionate approach means, and how Quality by Design influences clinical study planning.
The discussion also addresses the RBM requirements of ICH E6(R3) and the steps involved in implementing RBQM within an organization, providing a clearer basis for applying these related approaches in clinical research operations.
Risk-Based Quality Management (RBQM) and Risk-Based Monitoring (RBM) are closely connected within modern clinical trial management, but their distinct purposes can create confusion during implementation.
Connect ICH E8(R1) and ICH E6(R3). ICH E8(R1) introduces Quality by Design and a risk-proportionate approach to clinical studies, while ICH E6(R3) addresses the application of these principles within Good Clinical Practice. Understanding this relationship is important for determining how quality considerations and monitoring activities should be approached throughout clinical studies.
By the end of this session, participants will be equipped to apply RBQM and RBM consistently with current ICH expectations.
Apply ICH E8(R1) principles for Risk-Based Quality Management.
Understand ICH E6(R3) requirements for Risk-Based Monitoring.
Distinguish RBQM from RBM and explain how they relate.
Apply Quality by Design to clinical study planning.
Identify Critical to Quality factors for a clinical study.
Plan risk-proportionate RBQM implementation steps within your organization.
Focused areas that will strengthen how your organization manages quality and monitoring in clinical trials.
Clarify the distinct purposes of RBQM and RBM and how they work together in trial management.
Identify the factors that matter most to participant protection and reliable results.
Build quality into clinical study planning in line with ICH E8(R1).
Take a risk-proportionate, practical path to implementing RBQM within your organization.
The principles and practical steps behind risk-based quality and monitoring in clinical research.
Clinical research professionals responsible for trial quality, oversight, and monitoring.
Clinical Operations Departments
Quality Assurance Departments
Data Management Departments
Clinical Project Managers
Clinical Operations Managers
Biostatisticians
Clinical Trial Managers
ICH E8(R1) introduced Quality by Design and a risk-proportionate approach to clinical studies, asking sponsors to identify the factors critical to quality before a trial begins. ICH E6(R3) carries these principles into Good Clinical Practice, including expectations for risk-based monitoring.
RBQM and RBM are closely connected, but treating them as the same thing — or implementing one without the other — creates confusion about how quality considerations and monitoring activities should be planned and executed.
This webinar clarifies the relationship between the two guidelines and the two approaches, and lays out practical steps for implementing RBQM in clinical research operations.
Nelle Stocquart has worked in clinical research since 2003, beginning in IVRS project management before becoming a Clinical Research Associate and subsequently managing clinical studies for CROs and pharmaceutical companies.
Her experience spans international Phase I through Phase IV studies, clinical project management, and team leadership, supporting the practical implementation of risk-based approaches in clinical research operations.
Don't miss this essential training on implementing RBQM and RBM under ICH E6(R3). Secure your spot now.